Simplex Trading, LLC Ligand Pharmaceuticals Inc Transaction History

Simplex Trading, LLC

$195 Billion
Q3 2025

A detailed history of Simplex Trading, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 1,647 shares of LGND stock, worth $330,816. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,647

Previous 540 205.0%

Holding current value

$330,816

Previous $61,000 377.05%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$112.56 - $177.14 $124,603 - $196,093	1,107 Added 205.0%	1,647 $291,000
Q2 2025 Aug 05, 2025	BUY	$96.67 - $118.22 $52,201 - $63,838	540 New	540 $61,000
Q4 2024 Feb 11, 2025	BUY	$99.95 - $129.9 $54,172 - $70,405	542 New	542 $58,000
Q2 2023 Aug 04, 2023	BUY	$69.53 - $79.33 $13,002 - $14,834	187 New	187 $13,000
Q4 2022 Feb 02, 2023	SELL	$61.72 - $96.74 $802 - $1,257	-13 Reduced 3.41%	368 $24,000

Q3 2022 Nov 04, 2022	SELL	$0.01 - $107.56 $70 - $763,245	-7,096 Reduced 94.9%	381 $32,000
Q2 2022 Aug 03, 2022	BUY	$74.52 - $117.06 $546,380 - $858,283	7,332 Added 5056.55%	7,477 $667,000
Q1 2022 May 02, 2022	BUY	$94.99 - $151.56 $13,773 - $21,976	145 New	145 $16,000
Q1 2020 Apr 29, 2020	SELL	$63.37 - $107.88 $134,851 - $229,568	-2,128 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$96.94 - $113.59 $130,287 - $152,664	1,344 Added 171.43%	2,128 $221,000
Q3 2019 Oct 15, 2019	BUY	$86.25 - $120.16 $67,620 - $94,205	784 New	784 $78,000
Q4 2018 Jan 16, 2019	SELL	$128.36 - $272.13 $312,941 - $663,452	-2,438 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$211.18 - $274.49 $96,720 - $125,716	458 Added 23.13%	2,438 $669,000
Q2 2018 Jul 30, 2018	BUY	$150.77 - $207.98 $298,524 - $411,800	1,980 New	1,980 $410,000
Q1 2018 Apr 26, 2018	SELL	$138.63 - $182.62 $278,230 - $366,518	-2,007 Closed	0 $0
Q4 2017 Jan 10, 2018	BUY	$128.36 - $147.04 $53,526 - $61,315	417 Added 26.23%	2,007 $274,000
Q3 2017 Oct 25, 2017	BUY	$120.91 - $137.94 $192,246 - $219,324	1,590	1,590 $216,000

Others Institutions Holding LGND

# of Institutions

343

Shares Held

36.3M

Call Options Held

19K

Put Options Held

11.5K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $3.39B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Ligand Pharmaceuticals Inc Transaction History